← All organizations
Hanmi Pharmaceutical
For profitWebsite ↗
Also known as: Hanmi pharma. | Hanmi Pharmaceutical co., ltd. | Hanmi Pharmaceutical Co., Ltd. | Hanmi Pharmaceutical Company Limited | Hanmi Pharmaceutical Company Limited ( e-mail: kmpark@hanmi.co.kr ) | Hanmi pharmaceuticals | Hanmi Pharmaceuticals | Hanmi Pharmaceuticals.Co.,Ltd | HANMI PHARMA CO.,Ltd | Hanmi Pharm. Co., Ltd. | Zhejiang Hanmai Pharmaceutical Technology Co., Ltd.
Highest phase reached
Phase 4
Timeline
1970s
- Jan 1, 1973
Hanmi Pharmaceutical— Founded
2010s
- Aug 6, 2013
esomeprazole— Marketing Organization
Drugs by trial phase (134 distinct, 190 trials)
Phase 4 (18 own, 0 via acquisition)
Phase 3 (37 own, 0 via acquisition)
Phase 2 (24 own, 0 via acquisition)
Phase 1 (55 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Adenocarcinoma of Lung
- Aortic Valve Insufficiency
- Aortic Valve Stenosis
- Arthritis
- Arthritis, Rheumatoid
- Asthma
- Back Pain
- Body Weight
- Breast Neoplasms
- Bronchitis
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Cerebrovascular Disorders
- Cognitive Dysfunction
- Coronary Artery Disease
- Coronary Disease
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Diarrhea
- Dwarfism, Pituitary
- Dyslipidemias
- Endocrine System Diseases
- Erectile Dysfunction
- Essential Hypertension
- Fatty Liver
- Gastroesophageal Reflux
- Gastrointestinal Stromal Tumors
- Glomerulonephritis
- Glomerulonephritis, Membranous
- Heart Diseases
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis C
- Hepatitis C, Chronic
- Hepatitis, Chronic
- Hypercholesterolemia
- Hyperlipidemias
- Hyperlipoproteinemias
- Hyperplasia
- Hypertension
- Hypertension, Pulmonary
- Hypertrophy
- Hypertrophy, Left Ventricular
- Infections
- Irritable Bowel Syndrome
- Kidney Diseases
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Low Back Pain
- Lung Diseases, Obstructive
- Lung Neoplasms
- Metabolic Syndrome
- Muscle Cramp
- Myocardial Ischemia
- Neoplasms
- Non-alcoholic Fatty Liver Disease
- Obesity
- Obesity, Abdominal
- Overweight
- Plaque, Atherosclerotic
- Prostatic Hyperplasia
- Pulmonary Disease, Chronic Obstructive
- Renal Insufficiency, Chronic
- Respiratory Tract Infections
- Rhinitis
- Rhinitis, Allergic
- Rhinitis, Allergic, Perennial
- Rhinitis, Vasomotor
- Spasm
- Stomach Neoplasms
- Stroke
- Syndrome
- Urinary Bladder, Overactive
Marketed drugs (1)
Recent trials (50)
- NCT07297693Lead sponsorPhase 1Dec 19, 2025
- NCT07219589Lead sponsorPhase 1Nov 6, 2025
- NCT07205900Lead sponsorPhase 2Oct 31, 2025
- NCT06858397CollaboratorPhase 1/Phase 2May 14, 2025
- NCT06767345CollaboratorPhase 4May 12, 2025
- NCT06724016Lead sponsorPhase 1Dec 11, 2024
- NCT06595004Lead sponsorPhase 3Nov 20, 2024
- NCT06649240CollaboratorN/AOct 4, 2024
- NCT06518122Lead sponsorPhase 1Aug 31, 2024
- NCT06481098Lead sponsorPhase 1May 28, 2024
- NCT06357910Lead sponsorPhase 1May 17, 2024
- NCT06361108Lead sponsorPhase 1May 16, 2024
- NCT06346184Lead sponsorPhase 1May 2, 2024
- NCT06174766Lead sponsorPhase 3Apr 1, 2024
- NCT06438172Lead sponsorPhase 3Mar 25, 2024
Details
- Founded
- Seoul, KR Jan 1, 1973
- Last known activity
- Dec 19, 2025